These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37257418)

  • 1. Change of iron content in brain regions after intravenous iron therapy in restless legs syndrome: quantitative susceptibility mapping study.
    Kim TJ; Kim MH; Kim JH; Jun JS; Byun JI; Sunwoo JS; Shin JW; Gho SM; Sohn CH; Jung KY
    Sleep; 2023 Aug; 46(8):. PubMed ID: 37257418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferric carboxymaltose effects on restless legs syndrome and on brain iron in patients with iron deficiency anemia.
    Bae H; Cho YW; Kim KT; Li X; Earley CJ
    Sleep Med; 2023 Sep; 109():128-131. PubMed ID: 37437492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different iron deposition patterns in hemodialysis patients with and without restless legs syndrome: a quantitative susceptibility mapping study.
    Wang H; Han X; Jin M; Wang LY; Diao ZL; Guo W; Zhang P; Wang Z; Ding HY; Lv H; Zhang ZY; Zhao PF; Li J; Yang ZH; Liu WH; Wang ZC
    Sleep Med; 2020 May; 69():34-40. PubMed ID: 32045852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain iron deficiency in idiopathic restless legs syndrome measured by quantitative magnetic susceptibility at 7 tesla.
    Li X; Allen RP; Earley CJ; Liu H; Cruz TE; Edden RAE; Barker PB; van Zijl PCM
    Sleep Med; 2016 Jun; 22():75-82. PubMed ID: 27544840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous iron administration in restless legs syndrome : An observational study in geriatric patients.
    Lieske B; Becker I; Schulz RJ; Polidori MC; Kassubek J; Roehrig G
    Z Gerontol Geriatr; 2016 Oct; 49(7):626-631. PubMed ID: 26597718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron for the treatment of restless legs syndrome.
    Trotti LM; Becker LA
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD007834. PubMed ID: 30609006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient characteristics predicting responses to intravenous ferric carboxymaltose treatment of restless legs syndrome.
    Park HR; Choi SJ; Joo EY; Allen RP
    Sleep Med; 2020 Nov; 75():81-87. PubMed ID: 32853922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the response to intravenous iron in restless legs syndrome: an observational study.
    Hornyak M; Scholz H; Kiemen A; Kassubek J
    Sleep Med; 2012 Jun; 13(6):732-5. PubMed ID: 22503006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, placebo-controlled trial of ferric carboxymaltose in restless legs syndrome patients with iron deficiency anemia.
    Bae H; Cho YW; Kim KT; Allen RP; Earley CJ
    Sleep Med; 2021 Aug; 84():179-186. PubMed ID: 34157632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy and safety of intravenous ferric carboxymaltose treatment for restless legs symptoms and low serum ferritin in children with autism spectrum disorder.
    DelRosso LM; Reuter-Yuill LM; Cho Y; Ferri R; Mogavero MP; Picchietti DL
    Sleep Med; 2022 Dec; 100():488-493. PubMed ID: 36265207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of the International Restless Legs Syndrome Study Group rating scale with the Clinical Global Impression severity scale, the restless legs syndrome 6-item questionnaire, and the restless legs syndrome-quality of life questionnaire.
    Allen R; Oertel W; Walters A; Benes H; Schollmayer E; Grieger F; Moran K; Kohnen R
    Sleep Med; 2013 Dec; 14(12):1375-80. PubMed ID: 24246378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting brain iron deficiency in restless legs syndrome using magnetic resonance imaging.
    Beliveau V; Stefani A; Birkl C; Kremser C; Gizewski ER; Högl B; Scherfler C
    Neuroimage Clin; 2022; 34():103024. PubMed ID: 35500370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower molecular weight intravenous iron dextran for restless legs syndrome.
    Cho YW; Allen RP; Earley CJ
    Sleep Med; 2013 Mar; 14(3):274-7. PubMed ID: 23333678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open-label study of the efficacy and safety of intravenous ferric carboxymaltose in pregnant women with restless legs syndrome.
    Schneider J; Krafft A; Manconi M; Hübner A; Baumann C; Werth E; Gyr T; Bassetti C
    Sleep Med; 2015 Nov; 16(11):1342-1347. PubMed ID: 26498233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron for restless legs syndrome.
    Trotti LM; Bhadriraju S; Becker LA
    Cochrane Database Syst Rev; 2012 May; 5(5):CD007834. PubMed ID: 22592724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post Hoc Analysis of Data from Two Clinical Trials Evaluating the Minimal Clinically Important Change in International Restless Legs Syndrome Sum Score in Patients with Restless Legs Syndrome (Willis-Ekbom Disease).
    Ondo WG; Grieger F; Moran K; Kohnen R; Roth T
    J Clin Sleep Med; 2016 Jan; 12(1):63-70. PubMed ID: 26446245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Improvement of Low Serum Ferritin Improve Symptoms of Restless Legs Syndrome in a Cohort of Pediatric Patients?
    Rosen GM; Morrissette S; Larson A; Stading P; Barnes TL
    J Clin Sleep Med; 2019 Aug; 15(8):1149-1154. PubMed ID: 31482837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined resting state functional magnetic resonance imaging and diffusion tensor imaging study in patients with idiopathic restless legs syndrome.
    Zhuo Y; Wu Y; Xu Y; Lu L; Li T; Wang X; Li K
    Sleep Med; 2017 Oct; 38():96-103. PubMed ID: 29031764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of intravenous iron for patients with restless legs syndrome: evidence from randomized trials and observational studies.
    Yang X; Yang B; Ming M; Li S; Wang F; Zhu Z; Ji C; Long J; Hu F; Xu Z; Ren H; Liu B
    Sleep Med; 2019 Sep; 61():110-117. PubMed ID: 31395522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial.
    Allen RP; Adler CH; Du W; Butcher A; Bregman DB; Earley CJ
    Sleep Med; 2011 Oct; 12(9):906-13. PubMed ID: 21978726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.